FWQRC: The Global GxP & Regulatory Consultant Revolutionizing Life Science Sector

Duraimurugan Anbalagan, CEO

Duraimurugan Anbalagan

CEO

The worldwide pharmaceuticals market, which was valued at $1.6 trillion in 2023, is undergoing exponential growth in the post-covid era. As the industry advances with technological shifts making a tremendous impact along with highly stringent regulatory and compliance norms being introduced, the demand for pharmaceutical consultants is also rising at a rapid rate. In the dynamic world of life sciences, one organization stands out for its commitment to quality and regulatory compliance - FWQRC (Fire Water Quality & Regulatory Consultant). Established in 2018, FWQRC has evolved over the past five years into a leading business-to-business service organization based in Hyderabad, India.

FWQRC is registered with the Government of India under form GST REG-06 and has been complying with the regulations since January 2019. This aligns with FWQRC’s mission to provide high-quality services to achieve a high level of customer satisfaction at all times.

In addition, FWQRC is also registered under MSME and UDYAM Registration which is a new process for MSME registration launched by the Indian Government. This additional registration further validates the organization’s active status and commitment to regulatory compliance. Also, FWQRC is registered under the Dun & Bradstreet database where the DUNS Number is a unique nine-digit identifier for businesses. This registration allows other companies, government agencies, and financial institutions to confirm that FWQRC is an active business owner.

Duraimurugan Anbalagan, Pioneering Excellence in Global Regulatory Consultancy

In the dynamic landscape of life sciences, where precision and compliance are paramount, one name stands out:

Duraimurugan Anbalagan, PCQI. As the visionary Founder of FWQRC -Global GxP & Regulatory Consultant, he has steered the organization toward unparalleled success since its inception in Sep 2018.

Duraimurugan’s journey began with a passion for quality and regulatory affairs. Armed with certifications as a IRCA Certificated Lead Auditor Pharmaceutical Quality Management system (GMP) and a Lean Six Sigma Black Belt, Member of CQI, IRCA, he embarked on a mission to transform the industry. His unwavering commitment to excellence led him to become a Qualified Lead Auditor for ISO standards, including ISO 9001, ISO 14001, ISO 45001, ISO 22000, ISO 14298, and ISO 13485.

FWQRC is not just a service provider; it’s a partner in success, ensuring that companies can navigate the regulatory landscape with confidence & bring their products to market efficiently & effectively

Duraimurugan Anbalagan, CEO

Today, Duraimurugan’s expertise extends across two decades, during which he has left an indelible mark on the drug substance and drug product pharmaceutical industries. His insights into regulatory compliance have guided numerous startups, small businesses, and midsize companies worldwide. Whether it’s navigating the complexities of FDA approvals or ensuring adherence to international standards, Duraimurugan’s guidance has been invaluable.

FWQRC, a Beacon of Trust

FWQRC, headquartered in Hyderabad, India, operates as a business-to-business service organization. Driven by a group of seasoned technocrats, FWQRC provides tailored services in Regulatory Affairs, Quality Assurance, and Quality Control. Their clientele spans the globe, including the US, Latin America, Europe, Brazil, and Asia.

Over the span of five years, FWQRC has grown from a fledgling startup into a global leader in the life science sector. This journey has been marked by a steadfast commitment to quality, regulatory compliance, and client satisfaction. A significant part of this evolution has been its collaboration with several national and multinational organizations, which has allowed FWQRC to expand its reach and enhance its services.

Duraimurugan’s leadership philosophy revolves around holistic solutions. Aligned with its mission, today, FWQRC offers a comprehensive suite of services Auditing Services: Rigorous audits to ensure compliance and identify areas for improvement; Regulatory Services: Expert guidance through the regulatory maze; Quality Consultation Services:

Tailored strategies for quality enhancement; Training Services: Empowering professionals with knowledge and ISO Inspections and Certification Services: Navigating ISO standards seamlessly. These services are extended to small and mid-sized food, drugs, cosmetics, and medical device manufacturers across the globe, and are tailored effectively to suit the unique requirements of each business and each industry.

Established with the aim of empowering small and medium-scale industries that often lack ample funds to hire consultants to fulfill and implement regulatory requirements, FWQRC is bridging the gap in the industry, and giving such companies a chance to enhance their compliance with regulatory and compliance norms. FWQRC came forward as a cost-effective partner. Its team of professionals, driven by a group of pharmaceutical experts, has decades of experience in Regulatory Affairs, Quality Assurance, and Quality Control.

Mission & Vision

The mission of FWQRC is to provide clients with the highest quality of Regulatory Affairs, Quality Assurance, and Quality Control services. This allows their clients to operate continuously in compliance with local and global regulatory requirements and quality standards, bring their products to market faster, extend their business globally with minimum risk and reduced cost, and focus on their core business.

The Future of FWQRC

 FWQRC has helped many life science companies register their products successfully and efficiently in the US, Latin America, Europe, Brazil, and Asia. They are committed to providing high-quality services to their customers to achieve a high level of customer satisfaction at all times.

As FWQRC continues to grow and expand its services, it remains steadfast in its commitment to quality and regulatory compliance. The organization is poised to continue its influential role in the life sciences sector, guiding companies through the complex landscape of global regulatory requirements and quality standards.

In conclusion, FWQRC is not just a service provider; it’s a partner in success, ensuring that companies can navigate the regulatory landscape with confidence and bring their products to market efficiently and effectively.

As FWQRC continues to thrive under Duraimurugan’s guidance, it remains a beacon of trust for life science companies. His vision, coupled with a relentless pursuit of excellence, has solidified FWQRC’s position as a global leader. In the words of Duraimurugan Anbalagan himself, "FWQRC is a one-stop solution for all your needs. Choose us to accomplish the need of yours".

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.